UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...

Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they ...

A hidden communication network between brain cells and glioblastoma tumors may be key to slowing this aggressive cancer.

A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.

The growing use of immuno-oncology, advancing bioinformatics analysis, and rising investment in precision medicine are driving the immune repertoire sequencing market.Austin, Texas, Jan. 22, 2026 ...

Scientists have demonstrated a dependable method to generate large numbers of helper T cells from stem cells, removing a long-standing obstacle that has limited immune-based cancer treatments. The ...

Ianalumab targets the BAFF receptor, depleting malignant B cells and enhancing ibrutinib's efficacy, offering a potential ...

A mouse study suggests estrogen may increase gut pain by activating specific cells, offering hints to why IBS is more common ...

Study suggests CD4+ T cells mediate these immune-related toxicities ...

A deep dive into the Fc–FcR axis as a therapeutic anchor in autoimmune disease, examining immune signaling and drug ...

ImmunityBio’s stock rose nearly 40% after it announced the Phase I data and Anktiva sales figures for 2025.

Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, ...